Clinical Trial Update: Treatment of Relapsed/Refractory Intracranial Glioma in Patients Under 22 Years of Age [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial update for relapsed/refractory intracranial glioma in patients under 22 years, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anaplastic Astrocytoma
• Diffuse Intrinsic Brainstem Glioma
• Diffuse Intrinsic Pontine Glioma
• Fibrillary Astrocytoma
• Glioblastoma
• Oligodendroglioma

Snippet

Sponsor: University of Miami | Conditions: Glioblastoma Multiforme, Anaplastic Astrocytoma | Phase 1, Phase 2 | Status: RECRUITING